First clinical trial with a medical device on anaphylaxis management
Randomized, open and cross-over clinical Trial to evaluate the satisfaction of a medical device (Smart case for epinephrine autoinjector + APP) for the management of anaphylaxis.
It is the first clinical trial with a medical device and app that evaluates its usefulness for the management of anaphylaxis
100 patients were randomized and 95 patients finalized the study in one of the largest hospitals in Europe (Tertiary University Hospital Vall d’Hebron).
Adherence, anxiety, satisfaction and usability were recorded and analysed.
Finished on May 2017
Provisional results coming soon